Crenezumab

N/A

Report date: 2024/02/28 16:03:34

Base Information

Drug NameCrenezumab
Drug Alias NameCrenezumabum (AC Immune/Genentech)ๅ…‹็‘žๅฅˆ็ ๅ•ๆŠ—ๅ…‹็‘ž็ ๅ•ๆŠ—Anti-Aฮฒ mAb (AC Immune/Genentech)ๅ…‹้›ทๅ†…ๆฒปๅ•ๆŠ— +[10]ย 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[41]ย 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche LtdGenentech Inc
Inactive CompaniesRoche (China) Holding Ltd
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG